Results 221 to 230 of about 72,117 (254)
Some of the next articles are maybe not open access.

Antisense oligonucleotides as therapeutics for hyperlipidaemias

Expert Opinion on Biological Therapy, 2005
Hyperlipidaemia, due to elevations of low-density lipoprotein cholesterol (LDL-C) or triglycerides (TGs), is recognised as a significant risk factor contributing to the development of coronary heart disease (CHD), the leading cause of morbidity and mortality in the Western world.
openaire   +2 more sources

Antisense technology: an overview and prospectus

Nature Reviews Drug Discovery, 2021
Stanley T Crooke   +2 more
exaly  

Antisense Oligonucleotides as Antiviral Agentsa

Annals of the New York Academy of Sciences, 1992
J, Coulson, A D, Malcolm
openaire   +3 more sources

Antisense oligonucleotide therapeutics

Expert Opinion on Investigational Drugs, 1999
openaire   +2 more sources

An Antisense Oligonucleotide Primer

Antisense and Nucleic Acid Drug Development, 1999
openaire   +2 more sources

Antisense Oligonucleotides

Accounts of Chemical Research, 1995
Alain De Mesmaeker   +3 more
openaire   +1 more source

Post-exposure antisense protection against lethal filoviruses?

Nature Reviews Drug Discovery, 2010
Flemming Alexandra
exaly  

Antisense Oligonucleotides

2010
Jean-Michel Scherrmann   +199 more
openaire   +1 more source

Antisense approval provides boost to the field

Nature Reviews Drug Discovery, 2013
Man Tsuey Tse
exaly  

Home - About - Disclaimer - Privacy